Precision Metagenomics: Rapid Metagenomic Analyses for Infectious Disease Diagnostics and Public Health Surveillance
- PMID: 28337072
- PMCID: PMC5360386
- DOI: 10.7171/jbt.17-2801-007
Precision Metagenomics: Rapid Metagenomic Analyses for Infectious Disease Diagnostics and Public Health Surveillance
Erratum in
-
[No title available]J Biomol Tech. 2017 Jul;28(2):95. doi: 10.7171/jbt.17-2801-007CX. Epub 2017 Jun 8. J Biomol Tech. 2017. PMID: 28630599 Free PMC article.
Abstract
Next-generation sequencing (NGS) technologies have ushered in the era of precision medicine, transforming the way we treat cancer patients and diagnose disease. Concomitantly, the advent of these technologies has created a surge of microbiome and metagenomic studies over the last decade, many of which are focused on investigating the host-gene-microbial interactions responsible for the development and spread of infectious diseases, as well as delineating their key role in maintaining health. As we continue to discover more information about the etiology of infectious diseases, the translational potential of metagenomic NGS methods for treatment and rapid diagnosis is becoming abundantly clear. Here, we present a robust protocol for the implementation and application of "precision metagenomics" across various sequencing platforms for clinical samples. Such a pipeline integrates DNA/RNA extraction, library preparation, sequencing, and bioinformatics analyses for taxonomic classification, antimicrobial resistance (AMR) marker screening, and functional analysis (biochemical and metabolic pathway abundance). Moreover, the pipeline has 3 tracks: STAT for results within 24 h; Comprehensive that affords a more in-depth analysis and takes between 5 and 7 d, but offers antimicrobial resistance information; and Targeted, which also requires 5-7 d, but with more sensitive analysis for specific pathogens. Finally, we discuss the challenges that need to be addressed before full integration in the clinical setting.
Keywords: antimicrobial resistance; microbiome; next-generation sequencing; pathogen detection.
Figures

Similar articles
-
Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection.Annu Rev Pathol. 2019 Jan 24;14:319-338. doi: 10.1146/annurev-pathmechdis-012418-012751. Epub 2018 Oct 24. Annu Rev Pathol. 2019. PMID: 30355154 Free PMC article. Review.
-
Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection.Arch Pathol Lab Med. 2017 Jun;141(6):776-786. doi: 10.5858/arpa.2016-0539-RA. Epub 2017 Feb 7. Arch Pathol Lab Med. 2017. PMID: 28169558
-
Next Generation Sequencing and Bioinformatics Methodologies for Infectious Disease Research and Public Health: Approaches, Applications, and Considerations for Development of Laboratory Capacity.J Infect Dis. 2020 Mar 28;221(Suppl 3):S292-S307. doi: 10.1093/infdis/jiz286. J Infect Dis. 2020. PMID: 31612214 Review.
-
Messages from the third International Conference on Clinical Metagenomics (ICCMg3).Microbes Infect. 2019 Aug-Sep;21(7):273-277. doi: 10.1016/j.micinf.2019.02.004. Epub 2019 Mar 2. Microbes Infect. 2019. PMID: 30836173
-
Application of Next Generation Sequencing in Laboratory Medicine.Ann Lab Med. 2021 Jan;41(1):25-43. doi: 10.3343/alm.2021.41.1.25. Epub 2020 Aug 25. Ann Lab Med. 2021. PMID: 32829577 Free PMC article. Review.
Cited by
-
MegaD: Deep Learning for Rapid and Accurate Disease Status Prediction of Metagenomic Samples.Life (Basel). 2022 Apr 30;12(5):669. doi: 10.3390/life12050669. Life (Basel). 2022. PMID: 35629336 Free PMC article.
-
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges.Mol Diagn Ther. 2024 Sep;28(5):513-523. doi: 10.1007/s40291-024-00727-9. Epub 2024 Jul 11. Mol Diagn Ther. 2024. PMID: 38992308 Review.
-
Metabolomics technology and bioinformatics for precision medicine.Brief Bioinform. 2019 Nov 27;20(6):1957-1971. doi: 10.1093/bib/bbx170. Brief Bioinform. 2019. PMID: 29304189 Free PMC article. Review.
-
Literature Review of Pathogen Agnostic Molecular Testing of Clinical Specimens From Difficult-to-Diagnose Patients: Implications for Public Health.Health Secur. 2024 Mar-Apr;22(2):93-107. doi: 10.1089/hs.2023.0100. Epub 2024 Apr 12. Health Secur. 2024. PMID: 38608237 Free PMC article. Review.
-
Offline Next Generation Metagenomics Sequence Analysis Using MinION Detection Software (MINDS).Genes (Basel). 2019 Jul 30;10(8):578. doi: 10.3390/genes10080578. Genes (Basel). 2019. PMID: 31366182 Free PMC article.
References
-
- Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl 2011;17 (Suppl 3):S34–S37. - PubMed
-
- Vartoukian SR, Palmer RM, Wade WG. Strategies for culture of ‘unculturable’ bacteria. FEMS Microbiol Lett 2010;309:1–7. - PubMed
-
- Liu YY, Wang Y, Walsh TR, et al. . Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161–168. - PubMed
-
- Kumar A, Roberts D, Wood KE, et al. . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–1596. - PubMed
-
- Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev 2011;89:46–52, 54, 56–61 passim. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials